@bmsnews
- likes
- 24
- replies
- 0
- reposts
- 6
- quotes
- 0
- views
- 3,968
- bookmarks
- 2
Post
#MEDIA: Announcing positive topline results from the Phase 3 ACTION-1 trial of an investigational @RayzeBio therapy in people with GEP-NETs, a rare and difficult-to-treat cancer. An important step forward for patients with limited treatment options. https://t.co/AF5zDmdDYv